MQ: Transforming Mental Health awards £1.5 million for four new psychological treatment studies

New flagship research programme aims to advance the scope of psychological therapies to improve effectiveness and access to treatment.

The mental health research charity MQ: Transforming Mental Health has today announced  £1.5 million in funding awards as the first major investment of its new flagship research programme PsyIMPACT.   The Awards will support innovative ways of providing more effective and accessible psychological treatments for common mental disorders, such as anxiety, depression and ADHD. 

PsyIMPACT was developed following a major international meeting last year to channel scientific advances, including new computer-based approaches, to tackle the major access and treatment challenges in psychological therapies.

Four projects have been awarded funding:


Cynthia Joyce, Chief Executive of MQ: Transforming Mental Health said: 'Psychological treatments help so many people. And we know that they have the potential to benefit many more. Our PsyIMPACT awards are developing effective tools, opportunities to better target therapies, and brand new interventions in areas where current treatments are limited. Research in this area has the potential to transform the scale and impact of psychological therapy in the UK, meaning more people can get access to care in a way that works for them.’

Professor Chris Fairburn, Professor of Psychiatry at the University of Oxford and MQ Trustee added ‘If we are to have the greatest impact with psychological therapies, it is critical that we explore novel ways of delivering and personalising interventions. I am delighted that MQ is funding four exciting projects to drive this agenda forward, taking advantage of the opportunities provided by the internet and modern technology.'

Commenting on MQ's funding announcment, Care and Support Minister, Norman Lamb MP said: "Mental health is a priority and psychological therapies are a lifeline for so many. That’s why we’ve invested over £450 million in improving access to these treatments. I’m pleased to see organisations like MQ investing in studies - we need to invest far more in understanding mental ill health and this is a brilliant initiative.”

Last updated: November 18, 2014